Klotho Neurosciences, Inc.

Biotechnology • Healthcare • Omaha, NE, United States • KLTOW (NCM)

Klotho Neurosciences, Inc. develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates consist of KLTO-101 for the treatment or prevention of Alzheimer's disease; and KLTO-202, a gene therapy product for treatment and prevention of Lou Gehrig's disease. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.

833 931 6330 13576 Walnut Street, Omaha, NE 68144, United States

Stock Performance (90 Days)

Data through Dec 29, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Klotho Neurosciences enters securities purchase agreement - MSN

MSN • Dec 24

Klotho Neurosciences Signs Letter of Intent to Acquire Select Assets from Turn Biotechnologies, Anchored by $300 Million Global Pharma Partnership - PR Newswire

PR Newswire • Sep 30

Klotho Neurosciences enters agreement to sell Series C preferred stock to Sigma9 Capital - Investing.com

Investing.com • Dec 8

What's Happening With Klotho Neurosciences Stock? - Nasdaq

Nasdaq • Jun 11

Klotho Neurosciences, Inc. (KLOTHO) Initiates Manufacturing of KLTO-202 Product Candidate Using AAVnerGene's Platform Technology - Yahoo Finance

Yahoo Finance • Aug 12

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Klotho Neurosciences, Inc. had layoffs?

No layoff events have been recorded for Klotho Neurosciences, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Klotho Neurosciences, Inc. have?

Klotho Neurosciences, Inc. has approximately 3 employees.

What industry is Klotho Neurosciences, Inc. in?

Klotho Neurosciences, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Klotho Neurosciences, Inc. a publicly traded company?

Yes, Klotho Neurosciences, Inc. is publicly traded under the ticker symbol KLTOW on the NCM.

Where is Klotho Neurosciences, Inc. headquartered?

Klotho Neurosciences, Inc. is headquartered in Omaha, NE, United States at 13576 Walnut Street, Omaha, NE 68144, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.